MDT
Medtronic plc · Healthcare · Medical - Devices
Momentum-inputs (vergelijkbare managers):
breedte van houders -4.5% ·
aandelenstroom -6.2% ·
netto nieuwe posities -4.8%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 174 | +1 | 858.09M | $68.40B | +6 | −5 |
| Q1 2026 | 176 | +1 | 881.81M | $77.21B | +3 | −3 |
| Q4 2025 | 174 | 0 | 922.24M | $88.62B | +1 | — |
| Q3 2025 | 25 | -2 | 519.60M | $49.51B | — | −3 |
| Q2 2025 | 25 | +1 | 407.26M | $35.53B | +1 | — |
| Q1 2025 | 21 | 0 | 149.92M | $13.50B | +1 | −1 |
| Q4 2024 | 21 | -1 | 154.76M | $12.40B | — | −1 |
| Q3 2024 | 21 | +1 | 104.49M | $9.40B | +1 | — |
| Q2 2024 | 20 | — | 97.49M | $7.67B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 60.44M | — | $4.87B | 0.2% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 27.06M | +2.2% | $2.16B | 0.2% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passief) | 27.06M | +2.2% | $2.16B | 0.2% | ▲ Add | 3 | SEC ↗ |
| 4 | Norges Bank ✦ (passief) | 14.57M | +0.5% | $1.16B | 0.2% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 12.39M | -32.6% | $989.92M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 12.39M | -32.6% | $989.92M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 12.39M | -32.6% | $989.92M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 12.39M | -32.6% | $989.92M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 12.39M | -32.6% | $989.92M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 12.39M | -32.6% | $989.92M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 12.39M | -32.6% | $989.92M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 12 | Dodge & Cox ✦ | 7.66M | +13.3% | $611.97M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 7.04M | +1.5% | $562.46M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 7.04M | +1.5% | $562.46M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 15 | Fisher Asset Management ✦ | 6.07M | +3.0% | $485.16M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 5.97M | +2.6% | $476.88M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 5.97M | +2.6% | $476.88M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 2.61M | +21.7% | $208.20M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 2.61M | +21.7% | $208.20M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 2.61M | +21.7% | $208.20M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 2.61M | +21.7% | $208.20M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 2.61M | +21.7% | $208.20M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 2.61M | +21.7% | $208.20M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 2.07M | +486.0% | $165.61M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 2.07M | +486.0% | $165.61M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 26 | Adage Capital Partners ✦ | 1.66M | +7.2% | $132.26M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 27 | Millennium Management ✦ | 1.55M | -75.1% | $123.73M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 28 | Arrowstreet Capital ✦ | 1.18M | -66.4% | $94.48M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 29 | Point72 Asset Management ✦ | 1.02M | +11.1% | $81.79M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 30 | PRIMECAP Management ✦ | 727.18K | -15.9% | $58.09M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 31 | Renaissance Technologies ✦ | 575.34K | -56.2% | $45.96M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 32 | Two Sigma Investments ✦ | 563.43K | -58.4% | $45.01M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 33 | Baillie Gifford ✦ | 517.38K | -2.8% | $41.33M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 34 | Baillie Gifford ✦ | 517.38K | -2.8% | $41.33M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 35 | Baillie Gifford ✦ | 517.38K | -2.8% | $41.33M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 36 | Baillie Gifford ✦ | 517.38K | -2.8% | $41.33M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 37 | Bridgewater Associates ✦ | 511.35K | -12.2% | $40.85M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 38 | Marshall Wace ✦ | 408.32K | +280.7% | $32.62M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 39 | Marshall Wace ✦ | 408.32K | +280.7% | $32.62M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 40 | Marshall Wace ✦ | 408.32K | +280.7% | $32.62M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 41 | Gotham Asset Management ✦ | 166.72K | -29.9% | $13.32M | 0.1% | ▼ Trim | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| GAMCO Investors | $300,880 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 2,204 houders, 1.04B aandelen, $87.65B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.